Australia markets open in 6 hours 14 minutes

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.28+0.33 (+5.46%)
As of 11:46AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close5.95
Bid6.22 x 800
Ask6.23 x 1400
Day's range5.77 - 6.37
52-week range4.69 - 17.25
Avg. volume4,994,141
Market cap1.922B
Beta (5Y monthly)2.25
PE ratio (TTM)N/A
EPS (TTM)-1.25
Earnings date11 May 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est26.67
  • GlobeNewswire

    Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment of Pain Due to Knee Osteoarthritis (OA)

    A Phase 2 trial of intra-articular RTX for knee OA pain has enrolled its first two patients.The injections were well tolerated and both patients were discharged home after a brief period of observation.Phase 1b data demonstrated significant efficacy supporting RTX as an ideal candidate for long-term control of refractory OA pain: significant pain relief observed in patients with advanced OA disease and sustained pain relief last beyond 6 months and in many cases longer than a year with several p

  • GlobeNewswire

    Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Pathologists

    Sorrento has received accreditation from the American College of Pathologists, which allows Sorrento to bill to Medicare and MedicaidSAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Sorrento’s Clinical Laboratory, located in San Diego, California, based on results of a recent on-site inspection as part of the CAP's Accreditation

  • GlobeNewswire

    Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil

    Sorrento has received orders from its logistics partner and a large diagnostic laboratory client for official commercial launch of COVISTIX™ COVID-19 Virus Rapid Antigen Detection Test in Brazil. SAN DIEGO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that initial loading orders have been processed and scheduled for delivery later this year. The initial shipment will establish an in-country safety stock to manage just in time ongoing de